DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the BALAJI AMINES LIMITED (BALAMINES) share price today?

BALAJI AMINES LIMITED (BALAMINES) is trading at ₹2,289.1 on the NSE, down 3.49% on the day. Source: DocStoX.

What is the PE ratio of BALAJI AMINES LIMITED?

BALAJI AMINES LIMITED has a price-to-earnings (PE) ratio of 44.4 in the Chemicals sector.

What is the market capitalisation of BALAJI AMINES LIMITED?

BALAJI AMINES LIMITED has a market capitalisation of approximately ₹7,438 crore.

BALAJI AMINES LIMITED

BALAMINES·NSE·Chemicals

₹2,289.10▼ -82.70 (-3.49%)

Chemicals · Specialty Chemicals

Revenue under pressure recently

Day₹2264.00

₹2389.00

52W₹968

₹244490%

Open

₹2389.00

High

₹2389.00

Low

₹2264.00

Prev Close

₹2371.80

Volume

1.28L

VWAP

₹2311.26

Snapshot

Key fundamentals

Market Cap

₹7,438 Cr

P/E Ratio

44.36Expensive

P/B Ratio

3.66

EPS

₹51.60

Book Value

₹610.00

ROE

8.74%Average

ROCE

11.00%Decent

Dividend Yield

0.50%

Debt / Equity

0.07Low

Face Value

₹2.00

52W High

₹2443.60

52W Low

₹968.10

Sector

Chemicals

Industry

Specialty Chemicals

Avoid

None moatHigh uncertainty

Fair value estimate

₹661

▼ 71.1%downside

Trading at ₹2,289 — 71% above our estimate

BearFair valueBull

₹562₹661₹842

/100

Business quality — Watch the fundamentals

Growth 0Profitability 37Efficiency 8Valuation 55

Plain English

Our view

Revenue under pressure recently
Virtually debt-free balance sheet
Revenue has been shrinking

Strengths

Virtually debt-free balance sheet
Promoters hold a controlling stake

Risks

Revenue has been shrinking
Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

9% ROE fading to 13% over ~3 yrs, on ₹610 book

₹580

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹842

Analyst target

No analyst coverage

—

Blended fair value₹661

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Promoters hold a controlling stake

Bear case

Revenue has been shrinking
Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

44.4Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

8.7%Average

Above 15% is considered healthy for Indian equities

ROCE

11.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.07Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹7,438 Cr

P/B

3.66

EPS

₹51.60

Div Yield

0.50%

What changed

Recent changes

Foreign investors-0.3% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 44.4×

Growth

Shrinking

-15% rev CAGR

Profitability

Modest

8.7% ROE

Financial health

Rock solid

D/E 0.07

Momentum

N/A

No technicals

Today

Trading activity

Delivery %39.8%

Turnover₹2954.43L Cr

Trades13,512

VWAP₹2311.26

Face value₹2.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-15.4%

+1.6%

10Y

+8.3%

Profit

-25.3%

-7.0%

10Y

+11.3%

EPS

-19.9%

-6.8%

10Y

+11.2%

Profile

Pros

Company is almost debt free.
Company has been maintaining a healthy dividend payout of 20.4%
Company's working capital requirements have reduced from 101 days to 68.8 days

Watch-outs

Cons

Stock is trading at 3.96 times its book value
The company has delivered a poor sales growth of 1.64% over past five years.
Company has a low return on equity of 9.92% over last 3 years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 0.31 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

55%

Promoter

Promoters

54.6%0.00

Public

41.0%+0.37

FII / FPI

3.0%-0.31

DII

1.5%-0.07

Total shareholders

1,15,754-1,837 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter54.59%

FII2.99%

DII1.46%

Public40.96%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporate in 1989, Balaji Amines Ltd is engaged in manufacturing of specialty chemicals, aliphatic amines, and derivatives, along with ownership of a five-star hotel in Solapur, Maharashtra.[1]